Axon Enterprise: A Deep Value Investing Analysis

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?6/10

  A

  Conclusion: the ceiling is high enough, but the essence is expanding and connecting an existing pie that is being digitized, not creating a brand-new market from nothing. That means its growth is driven by deeper penetration plus horizontal category expansion, not by opening an uncharted frontier.

  The underlying needs Axon serves - field recording, evidence management, command and dispatch for law enforcement, corrections, the courts, fire departments, and EMS - have existed for decades. What the company does is move fragmented, paper-based, localized workflows onto an integrated hardware + cloud + AI platform. The report positions it as a mission-critical platform around public safety scenes, evidence, command, and reporting. That assessment is right: Axon is digitizing and upgrading an installed market, not inventing a new need.

  How large the pie is, and how much deeper penetration can go, is anchored by three persuasive points in the report. First, demand is not saturated: the report cites NIJ research showing that larger police departments already have high body-worn camera deployment, but general-purpose agencies are not fully saturated, and the U.S. Department of Justice's FY 2025 BWC program is still funding new or expanded deployments. Second, the company's own unrealized demand is substantial: as of Q1 2026, future contracted bookings were about $14.3 billion and remaining performance obligations (RPO) were about $9.7 billion. Compared with its 2025 full-year revenue of about $2.78 billion, that is a signed runway of roughly five times that year's revenue. Third, the geographic ceiling is rising: the report discloses that U.S. revenue accounted for 83% in 2025, then fell to 80% in Q1 2026 as international rose to 20%, with overseas markets still opening as an incremental opportunity.

  Still, the expansion of an existing pie also contains elements of creating new markets, which is what makes Axon more attractive than a pure penetration story. AI report writing, Real-Time Operations, drones/counter-drone, and 911 call handling are categories that either lacked standardized products before Axon entered or had not been connected to field devices. The report discloses about $750 million in first full-year bookings for the AI Era Plan, more than 500 agencies using Axon Assistant within months of launch, and in Q1 2026 AI product revenue up more than 700% year over year and counter-drone revenue up more than 300%. In other words, inside the large pie of existing public safety budgets, Axon has baked several new layers that did not previously exist.

  To be candid, the biggest constraint is not the ceiling, but the nature of the funding source. Its customers are mainly governments and public budgets, so the expansion speed of the overall TAM is constrained by budget cycles, political controversy, procurement, and compliance timelines. It cannot spread exponentially like a consumer internet product. From a Baillie Gifford perspective, I would summarize it this way: the ceiling is high enough to support many years of double-digit growth, with volume from more agencies moving to the cloud, price from higher ARPU per agency as AI/command modules are added, and new businesses from drones/911/enterprise security. But it is a long slope with high visibility and a fiscal constraint on its gradient, not a new continent that can scale from nothing while ignoring the installed base.

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Will growth be driven mainly by volume, price, or new businesses?7/10

  A

  Conclusion: a revenue double over the next five years is almost a low bar. At the current growth rate, it could double in 1.5 to 2 years, and over five years it will very likely more than double. Growth is a combination of volume first, price second, and new businesses adding upside, with a huge order book already locking in much of the path.

  Start with how easy the arithmetic is. Axon has grown revenue by more than 30% for nine consecutive quarters, and Q1 2026 revenue was $807 million, up 34% year over year. Even if growth is conservatively assumed to decelerate year by year to the low 20%s, revenue easily doubles over five years; in fact, maintaining roughly a 15% CAGR is enough to reach about 2x in five years. Under the report's framing, revenue grew from $866 million in 2021 to $2.780 billion in 2025, a four-year CAGR of about 33.9%; the company's latest 2026 guidance has been raised to 30%-32% revenue growth. So whether Axon can double in five years is not the real question. The real question is whether it can far exceed a double.

  The growth driver mix, from both the report and the latest data, points to volume > price > new-business optionality:

  • Volume (the largest driver): more agencies on the platform, with more seats and devices deployed. The report says the company serves 17,000+ U.S. state and local agencies and covers 85+ countries. Penetration is far from capped, and international rising from 17% to 20% adds geographic volume growth. This is the revenue base.

  • Price (structural ARPU uplift): net revenue retention has held at 125%, meaning existing customers contribute about 25% same-store growth each year through add-ons and package upgrades alone, before new-customer growth. Customers are moving from buying standalone devices to higher-priced bundled subscriptions such as the AI Era Plan, evidence cloud, and real-time command, steadily lifting value per agency.

  • New businesses (upside optionality): AI reporting, drones/counter-drone, and 911 through Carbyne/Prepared are new curves moving from 0 to 1. In Q1 2026, AI product revenue grew more than 700% year over year and counter-drone grew more than 300%. The bases are small, but the slopes are steep, and these options can push a double toward a triple.

  More important, the visibility of this growth is unusually high. As of Q1 2026, future contracted bookings were about $14.3 billion and RPO was about $9.7 billion. The report notes that about 20%-25% of RPO is recognized over the next 12 months, with the rest usually delivered over the following decade. That means a substantial share of the incremental revenue needed for a five-year double is not something Axon hopes to sign in the future; it is already signed and waiting to be recognized. That is rare visibility for a growth stock.

  The honest boundaries: first, growth will inevitably slow as the base gets larger, so linearly extrapolating 30%+ through year 5 is not robust; second, volume growth depends on government budgets and deployment timelines, while price growth depends on AI package penetration not being compressed by competitors' price wars. Overall, however, on Baillie Gifford's most important test of doubling in five years, Axon not only clears the bar; it is one of the few names where a double looks close to the floor and a triple is the real bet.

  Jun 10, 2026
• QAfter five years, what will take over as the next growth engine? Does that second curve exist today?5/10

  A

  Conclusion: the second curve clearly exists today, and there is more than one. AI workflows, real-time command/911, and drones/counter-drone are the engines that can take over. Strictly speaking, though, they are more like same-origin extensions of the main platform than entirely new growth poles detached from the public safety core.

  This Baillie Gifford question requires separating two issues: whether new engines exist to take over after five years (yes, and they are accelerating), and whether those engines are truly independent of today's main curve built on TASER + evidence cloud (that deserves an honest discount).

  The second curve is already running; it is not a PowerPoint story:

  • AI workflows: Draft One for AI incident reports and Axon Assistant have been commercialized. The report discloses about $750 million in first full-year bookings for the AI Era Plan, and 500+ agencies adopting Axon Assistant within months of launch; in Q1 2026, AI product revenue grew more than 700% year over year. This curve has excellent unit economics because of software gross margins, and it directly lifts ARPU from existing customers.

  • Real-time command and 911: Axon entered through acquisitions of Fusus for real-time operations centers, and Carbyne and Prepared for next-generation 911 call handling. The report says Fusus processes more than 1 million live streams per month, and Carbyne's base consideration was $625 million while Prepared required about $624 million in cash. This moves Axon's coverage from after officers arrive on scene to the second a citizen calls 911, opening a new workflow entry point.

  • Drones and counter-drone: Axon entered counter-drone through Dedrone, alongside its own drone/Drone as First Responder efforts. In Q1 2026, counter-drone product revenue grew more than 300% year over year, a small-base but steep-slope pure incremental business.

  These are real successors rather than story stocks because they share the same customers, sales and deployment channels, and evidence/data foundation. Axon does not need to reacquire customers to sell new modules into 17,000+ existing agencies. That is exactly the engine behind 125% net revenue retention. The report accurately describes this closed loop as data - workflow - more modules - deeper embedding.

  But two honest discounts are necessary:

  First, the second curve is highly same-origin with the main curve. All of these businesses grow on the same public safety tree, sell to government customers, and face the same budget and regulatory constraints. The report highlights in its risks that the company has driven an aggressive acquisition expansion through Prepared, Fusus, Dedrone, and Carbyne. By Q1 2026, goodwill had risen to about $1.894 billion under the report's framing. That shows many second curves were bought, creating real risks of integration failure, cultural conflict, and overpayment. Baillie Gifford prefers second curves that are incubated internally and self-regenerating. Axon is a hybrid of internal AI plus acquired command/911/counter-drone, so its quality is not as clean as a purely organic curve.

  Second, the ceiling of the third curve has not yet been verified. Enterprise security and international markets are longer-range possibilities, but the report notes that 83% of revenue still came from the U.S. in 2025 and overseas had only just reached 20%. That curve is more a direction today than a realized growth engine.

  Baillie-style summary: Axon is rare because while its main curve is still running at 30%+ growth, its second curves in AI/911/counter-drone have already ignited and are contributing meaningful incremental growth. That is one of the core reasons it deserves a long-term growth label. But these engines are new oilfields on the same continent, not another continent, and some are assembled through acquisitions. Its regenerative capacity is stronger than that of most hardware companies, but weaker than that of truly great growth companies that can reinvent themselves across arenas.

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

  A

  Conclusion: the core moat is high switching costs from deep embedding in law enforcement/judicial workflows, the breadth of an integrated platform, and an evidence-data flywheel. Over the next three to five years, the direction is wider, but unevenly so. The software/workflow layer is deepening, while hardware entry points and pricing always face credible rivals such as Motorola. The main body is widening, but the edges remain under pressure.

  Break the moat into several parts and assess their strength and direction separately, because they are not the same thing:

  1) Switching costs - the strongest and still deepening. This is Axon's real core. Devices themselves can be replaced, but the report correctly says the real barriers are evidence storage, chain of custody, policy configuration, permission systems, workflows, reports, integrations with RMS/911/command platforms, and training/deployment inertia. Once a police department has years of evidence, court-usable audit trails, personnel permissions, and case workflows running on Evidence.com, migration means ripping up its compliance and operating habits, with very high risk. The quantitative proof is net revenue retention consistently at 125%: customers are not only staying, they are adding about 25% net more each year. The report captures it in one sentence: customers are not merely renewing; they are continually adding. This moat deepens with every additional hour of footage stored and every additional module connected.

  2) Breadth of integrated platform - strong and widening. Axon's differentiation is not that any single product is the best; it is that the company bundles field devices, evidence cloud, AI reports, real-time command, 911, and drones into a public safety operating system. The report notes that many competitors are capable only at individual points, with weaker full-stack integration. Through acquisitions such as Fusus/Carbyne/Prepared/Dedrone, Axon has connected the workflow from a citizen calling 911 through dispatch - scene - recording - evidence - review. In Q1 2026, AI product revenue grew more than 700% year over year and counter-drone grew more than 300%, showing customers are accepting the new pieces. The report's view is that the moat is broadly widening because competitors now have to copy not one product, but a whole system.

  3) Brand and trust - strong and stable. Public safety buyers purchase reliability, court usability, and institutional trust. The report discloses that the platform has recorded more than 60 million hours of video and that Fusus processes more than 1 million live streams per month. TASER/Evidence.com has clear mindshare in this field. This moat changes slowly, but it is hard to buy quickly with money.

  4) Regulatory/compliance barriers - medium. FedRAMP High, privacy, and evidence compliance form accumulated barriers of trusted delivery capability. The report accurately characterizes this as not an uncopyable exclusive license; it is more a threshold than an iron gate.

  5) Data flywheel - weak network effects plus strong data advantage. This is not a classic two-sided network, but more devices lead to more evidence and more live streams, making AI reporting, search, and dispatch more valuable. The report is restrained and accurate here: this is a data advantage, not a network effect, and its strength should not be mythologized.

  Three-to-five-year direction, stated honestly:

  Overall, the moat widens, but two pressure points must be marked. First, hardware entry points and the pricing layer are not the moat: the report explicitly says cost advantage is not core. Axon sells total cost of ownership and workflow value, not the cheapest devices, which means the entry layer can always be harassed by lower-priced rivals. Second, the largest rival is not weak: the report notes that Motorola Solutions, with about $11.68 billion in 2025 revenue and far larger than Axon, maps almost comprehensively across every key area: video, digital evidence, ALPR, real-time command, RMS, 911, drone management, and AI reports. It also has strong cash flow and channels. Other competitors include Genetec, Flock Safety, and Hexagon. The real risk is not that Motorola defeats Axon, but that it keeps Axon's growth and pricing power slightly below market expectations. Third, technology substitution risk exists: if customers shift toward more open multi-vendor stacks rather than integrated platforms, the bundle advantage weakens.

  Baillie-style summary: this is a real moat centered on switching costs, deepening through platform integration and data accumulation. The direction is clearly wider, and the AI era strengthens its workflow lock-in. That is the hard core of the bullish case. But it is not an impregnable monopoly: entry points can be disturbed by price, strong rivals compete closely, and regulatory barriers are not exclusive. It should be understood as a wide and widening main body with persistent friction at the edges, not a textbook unbridgeable moat.

  Jun 10, 2026
• QIf its core business is disrupted, does it have the gene for self-reinvention? How does it handle mistakes and bad news?6/10

  A

  Conclusion: the gene for self-reinvention clearly exists. The company's voluntary shift from conducted-energy weapon hardware vendor to software + AI platform was itself a successful act of self-disruption, and it is still accelerating the move toward AI. But the score must be discounted heavily on how it handles mistakes and bad news: a material weakness in revenue-recognition internal controls has still not been fully remediated, and the company restated financial statements in 2024, which does not inspire confidence in the speed of its correction of financial disclosure issues.

  This question has two implied layers: whether the company can reinvent itself if the core business is disrupted, and whether it faces mistakes and bad news directly or papers them over. Axon shows a clear contrast across the two, so they must be discussed separately.

  The self-reinvention gene - Axon is an honors student here.

  The most persuasive evidence is that Axon has already disrupted itself once: from a one-time hardware company selling TASER devices into a platform centered on evidence cloud and subscription software. The report discloses that software and services revenue accounted for about 43% of total revenue in 2025 (under the full-year Q4 2025 framing, software and services were $1.2027 billion / total revenue $2.7795 billion), with software segment gross margin of about 74%. For a company that began in hardware to shift nearly half of its revenue mix into high-gross-margin software is a living example of a core business being remade.

  More importantly, it did not rest after that successful transformation. It is again voluntarily cannibalizing itself in the AI wave: when tools such as Draft One could reduce reliance on certain traditional modules, the company chose to be the disruptor rather than wait to be hit. In Q1 2026, AI product revenue grew more than 700% year over year. The report rates its strategic consistency highly: the company has long stayed committed to a hardware + cloud + platform path rather than merely pursuing a short-term software valuation story. On Baillie Gifford's most prized quality - willingness to disrupt itself and avoid being trapped by its own success - Axon has genuinely delivered. Culturally, founder Rick Smith has long emphasized a mission-driven narrative externally, reducing gun deaths and using technology to reshape public safety. That kind of moonshot narrative usually comes with a higher tolerance for trial and error.

  Handling mistakes and bad news - this is where points must honestly be deducted.

  The sharper half of the Baillie question is how a company faces its own mistakes. Axon's performance here is far less attractive than its strategic transformation, and the report bluntly identifies three red flags:

  • First, by the end of 2024, management had determined that disclosure controls were ineffective and that a material weakness existed in internal controls related to revenue recognition for customer contracts. That weakness caused errors that the company described as immaterial in revenue, contract assets/liabilities, and RPO disclosures across 2022-2024 periods. The report notes that by 2025 this weakness still had not been fully remediated and ICFR was still deemed ineffective.

  • Second, in 2024 the company also restated prior financial statements because of errors in current/non-current presentation of convertible notes.

  • Third, as acquisitions and stock-based compensation grow more complex, the financial statements are becoming harder for investors to read through to owner earnings.

  This means Axon reacts quickly and self-reinventively to bad news about product/market disruption, but its correction cycle is long when the bad news concerns its own internal controls and financial disclosure. For a company growing 30%+ for multiple consecutive quarters and not short of cash, allowing a material weakness in revenue recognition to remain unresolved across years is itself a sign that bad news is not being handled cleanly enough. The report is right to list it as a clear valuation discount factor.

  Baillie-style summary: as a test case for self-reinvention, Axon is almost textbook positive. It has actively disrupted itself twice, hardware to software and traditional software to AI, and got both moves right. But how it handles mistakes depends on the object: with market and technology bad news, it is direct and aggressive; with bad news in its own financial controls, its transparency and repair speed do not yet match its business quality. A truly great long-term holding should be excellent on both. Axon has full marks for reinvention but falls short on self-correction, which is exactly the crack the report repeatedly emphasizes in keeping the rating at Watch rather than Buy.

  Jun 10, 2026
• QDoes management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profits for five to ten years out?6/10

  A

  Conclusion: the long-term view is strong, alignment is real but diluted in purity by heavy stock-based compensation, and the willingness to sacrifice current profit for the distant future is very strong. Overall this is highly credible in direction but needs a discount and monitoring; the report's 3/5 is strict but defensible.

  The three sub-dimensions in this Baillie question are all clearly yes for Axon, but every yes needs a but attached.

  1) Long-term view - strong, and behavior has matched words for years. Founder Rick Smith has led the company for a long time, and the company's narrative and capital allocation are intensely long-term: connecting customers all the way from scene to call, dispatch, recording, evidence, and review. The report accurately says Axon has consistently been long-term oriented and has stayed with the hardware + cloud + platform path rather than chasing a short-term software valuation story. It has even publicly set multi-year targets with high bars, such as 2028 targets for SBC dilution and FCF conversion. Few companies are willing to put long-term KPIs on the table for market scrutiny.

  2) Deep alignment with the company - real, but not a heavy-concentration version. The report discloses that Rick Smith still owns about 2.81 million shares, or about 3.5% of the company, while all directors and executives together own about 4.2%. Interests are not detached. That percentage is aligned, though not like founders who have most of their net worth in the stock. At the current market cap of about $37 billion, 3.5% corresponds to over $1 billion, a genuine large stake, but the percentage is significant rather than controlling. So the alignment is real money and directionally aligned, not the extreme version where the founder's entire fortune lives or dies with minority shareholders.

  3) Willingness to sacrifice current profit for five to ten years out - very strong, perhaps too strong. Axon is one of the most striking examples in the group here, but this is a double-edged sword. The evidence: the company prioritizes cash for R&D, sales and marketing, acquisitions, and ecosystem expansion rather than dividends or buybacks, resulting in a full-year 2025 GAAP net margin of only 4.5% (net income about $124.7 million). For a company growing revenue at 30%+, actively pressing current profit down to a single-digit net margin is hard evidence of sacrificing the short term for the long term. It continues to make large adjacent acquisitions, including Carbyne base consideration of $625 million and about $624 million in cash for Prepared. The direction is platform expansion, not cosmetic EPS management.

  Why it still needs discounted monitoring - three real flaws:

  First, stock-based compensation is too aggressive, diluting the purity. The report says the seven-year CEO Performance Award approved by shareholders in 2024 had a nominal value of about $150 million, with an unvested share fair value of about $386 million at the end of 2025; stock-based compensation added back in the 2025 cash flow statement reached about $634 million, consistent with the report and public data. The report's point is exact: although SBC emphasizes long-term and performance thresholds, economic dilution is real. Weighted-average basic shares rose from 71.09 million in 2022 to 80.15 million in Q1 2026. Management's own 2028 target admits annualized SBC dilution should fall below 2.5%, which in reverse tells us it is not low today. If sacrificing current profit is funded mainly by issuing shares, what is being sacrificed is minority shareholders' per-share ownership.

  Second, financial controls are imperfect. The unrepaired material weakness in revenue-recognition internal controls and the 2024 convertible-note presentation restatement mean management is strategically credible, but the rigor of its control systems still deserves a discount in any judgment of trustworthiness.

  Third, key-person risk. The report notes that Rick Smith has enormous influence over strategy, culture, and external narrative. That is an advantage and a single-point risk.

  Baillie-style summary: management is an honors student on long-term view and willingness to sacrifice current profit for the future, and alignment is real. These support the long-term holding case. But it uses very generous stock-based compensation to power that long-termism, shifting part of the long-term value from minority shareholders to management and employees. Combined with unrepaired internal-control weaknesses, trust has to be qualified by ongoing monitoring of dilution and controls. The report's 3/5 score is a reasonable compromise: full marks on direction, discounted purity.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulation?6/10

  A

  Conclusion: if Axon disappeared tomorrow, customers would miss it badly. Evidence chains, 911, and command systems are mission-critical infrastructure with very high switching risk, making Axon highly indispensable. The growth model is generally sustainable, but the claim that it does not depend on harming society or regulation needs honest conditions: its products naturally sit on the ethical firing line of law enforcement power, privacy, and AI surveillance, so social license is a soft spot it must continually maintain and one that can backlash.

  This Baillie question has two implied premises that must both be answered: indispensability, meaning how much pain customers feel if it disappears; and the social/regulatory sustainability of the growth model, meaning whether its way of making money harms society and invites regulatory backlash. For Axon, one is very hard, while the other carries real risk.

  Indispensability - very strong, close to a pull-the-plug-and-operations-stop level.

  Axon does not sell optional tools. It is embedded in the critical infrastructure of daily law enforcement and judicial operations. If it disappeared tomorrow:

  • Years of police video, court-usable audit trails, and case evidence are hosted on Evidence.com. The report says the platform has recorded more than 60 million hours of video. A supply interruption would effectively paralyze the evidence management system, a pain with legal consequences rather than the normal pain of switching vendors.
  • Real-time command and 911 handling, including Fusus processing more than 1 million live streams per month and next-generation 911 from Carbyne/Prepared, directly affect emergency response if they fail. This is the lifeline of public safety.
  • The other side of switching cost is indispensability: the report says the real barriers are evidence storage, chain of custody, permissions, workflows, and training/deployment inertia. Net revenue retention of 125% quantifies that customers cannot leave and keep using more.

  In Baillie terms, Axon has moved from vendor to an organ that cannot be removed from customer operations. This yes is very hard.

  Is the growth model sustainable and not harmful to society or regulation? Three conditions must be stated honestly.

  First, the business itself has positive social value, but it naturally sits on an ethical firing line. Axon's mission narrative is reducing gun deaths and improving law-enforcement accountability through body cameras and transparent evidence. Those are real positive externalities. But its products are surveillance, weapons, and AI-automated policing reports, inherently involving civil privacy, the boundaries of police power, and algorithmic bias. The faster and deeper it grows into law enforcement, the stricter the social scrutiny becomes. That creates structural tension with the idea of not harming society. It is not that Axon is doing evil; it is that the field it operates in is itself the center of social controversy.

  Second, existing regulatory/legal friction is real, not hypothetical. The report discloses that in the 2025 annual report, three antitrust class actions brought by municipal agencies were still progressing, Dedrone was involved in patent litigation, and the VieVu transaction had gone through an FTC administrative process. This shows its market position and expansion methods have already attracted real antitrust and legal challenges. Social and regulatory sustainability is not unconditional.

  Third, the most dangerous issue is not a single lawsuit, but the tail risk of losing social license. The report's risk list includes major antitrust, AI/privacy, or product-liability events impairing pricing power. If a major law-enforcement abuse, AI misjudgment causing a wrongful case, or large-scale privacy scandal were attributed to the Axon platform, regulatory tightening, procurement pauses, and brand damage could happen simultaneously. Such risks are low-probability but high-damage, and they come precisely from Axon's core product form.

  The subtle relationship between social license and indispensability: precisely because Axon is so indispensable and so deeply controls the eyes and records of law enforcement, society has stronger reasons to supervise it. The more indispensable it becomes, the brighter the regulatory spotlight can become. This is what makes Axon different from a normal SaaS company: its moat, deep embedding in law enforcement, is also its risk source, deep embedding in controversy.

  Baillie-style summary: on how much customers would miss it if it vanished tomorrow, Axon gives a near-perfect answer. It is a mission-critical public safety operating system with very high switching risk. But whether its growth model is sustainable and not harmful to society and regulation deserves a conditional pass: its core business has positive social value, but it always sits inside the ethical tension of law enforcement power and privacy, it already faces antitrust litigation, and it carries tail risk that social license could be withdrawn. It does not make money by harming society, but the field in which it makes money requires constant and careful maintenance of social trust. Once that trust is damaged, the backlash would come from the very place where its moat is deepest.

  Jun 10, 2026
• QWhat are the unit economics of this business, including gross margins and incremental returns? Do they improve or deteriorate with scale? Where does the money it earns go?6/10

  A

  Conclusion: unit economics are very good and improving with scale. Software segment gross margin is about 74%, net revenue retention of 125% creates strong incremental returns, and platform leverage is real. But the money earned is mostly consumed by reinvestment, large stock-based compensation, and acquisitions, so there is a clear funnel between good business-level unit economics and cash reaching owners' pockets. That is the most important item to monitor in this good business.

  This Baillie question should be split into three parts: whether unit economics are good, whether they improve or deteriorate with scale, and where the money earned goes.

  1) Unit economics - structurally excellent, with software as the engine.

  The report discloses 2025 gross margins by segment of about 48.7% for Connected Devices and 74.0% for Software & Services, with consolidated gross margin of about 59.7% (2024 comparables were about 49.4%, 74.1%, and 59.6%). This is a healthy structure: hardware is the entry device and ecosystem anchor, with solid and stable gross margin, while software is the high-gross-margin compounding engine. The more important incremental-return metric is net revenue retention consistently at 125%. That means every retained $1 of existing-customer revenue automatically becomes $1.25 the next year, and the incremental portion is mainly high-gross-margin software/AI modules. This is exactly the picture Baillie likes: the marginal economics of incremental revenue are better than the installed-base average.

  2) With scale - improving, and platform leverage is already showing up.

  The hardest evidence is margin expansion with scale: under the report's framing, adjusted EBITDA margin rose from 19.5% in 2022 to 25.5% in 2025 (adjusted EBITDA about $710 million). That shows fixed R&D, platform, and sales infrastructure being spread across a larger revenue base, so platform scaling is working. Software's share has continued to rise from a hardware-led mix to about 43% in 2025. Structurally, the business grows softer and more profitable as it grows. That is directional evidence of improving unit economics with scale.

  3) Where the money goes - this is the funnel in an otherwise good business, and it must be discussed honestly.

  Axon is a typical company that reinvests good unit economics rather than returning them to shareholders. The report describes this clearly:

  • Reinvestment and acquisitions come first; no dividends and no large buybacks: the company prioritizes cash for R&D, sales and marketing, acquisitions, and ecosystem expansion. Large acquisitions include Carbyne base consideration of $625 million and about $624 million in cash for Prepared. Under the report's framing, goodwill rose to about $1.894 billion by Q1 2026. The direction is rational, expanding the platform, but whether it is paying too much and whether integration delivers are real questions.

  • Large stock-based compensation consumes a big piece of real value: 2025 stock-based compensation was about $634 million. The report makes the key point: if SBC is treated as a real shareholder cost, the cash distributable to owners is clearly lower than headline figures suggest. This is the main reason good unit economics have not fully converted into owner cash.

  • Growth also consumes working capital: the report notes that 2025 contract assets rose to $761 million, up 56% year over year, and deferred commission assets rose to $333 million. As the subscription model expands, cash collection unfolds over multiple years and working capital visibly consumes cash. So it is not a simple cash cow. The evidence is 2025 free cash flow of only about $155 million against nearly $2.8 billion of revenue, implying a weak cash conversion rate. The company gives a 2026 free cash flow target of about $450 million, which needs to be delivered to prove conversion is improving.

  An honest view of return on invested capital (ROIC): in the investment checklist, the report marks whether capital returns are excellent as uncertain, and whether it can generate stable free cash flow as pass, but with volatile cash conversion. The reason is exactly this funnel: heavy SBC, high-goodwill acquisitions, and working-capital usage discount attractive gross margins and EBITDA by the time one reaches true return on invested capital.

  Baillie-style summary: Axon's business unit economics are genuinely good: 74% software gross margin, 125% net revenue retention, and margins rising with scale are high-quality traits of a platform growth stock. But it reinvests nearly all the money from this good business into growth, acquisitions, and stock-based compensation. Good unit economics therefore do not equal cash in shareholders' hands today. For long-term growth investors, letting good money keep compounding can be acceptable and even ideal. But the premise is that reinvestment and acquisitions earn high enough returns, and SBC dilution narrows as management promises. Otherwise this becomes the awkward case of a good business with good unit economics that still fails to deliver to owners for a long time.

  Jun 10, 2026
• QWhat conditions must all hold for it to rise fivefold in ten years? Are those conditions realistic? What expectations are embedded in today's stock price?2/10

  A

  Conclusion: a fivefold gain in ten years requires three things to hold simultaneously: sustained high double-digit growth off a high base, a large improvement in margins and cash conversion, and no major collapse in valuation multiples. The first two are realistic but tight; the third is the most fragile. At about $450 today, about $37 billion in market cap, and a trailing P/E of about 185x, the stock has already priced in a decade in which excellence is almost mandatory and mistakes are barely allowed. The margin of safety for buyers is extremely thin.

  First translate a fivefold return in ten years into testable conditions, then look at what today's share price implies.

  What conditions must all hold for a fivefold return in ten years:

  A fivefold return in ten years is roughly a 17.5% annualized share-price return. For a company that pays no dividend and relies on intrinsic value growth to drive the stock, the product of performance growth and valuation change must reach about 5x. Broken down, at least three things must happen simultaneously:

  1. The fundamentals must grow by about 5x, or more to offset multiple contraction. Starting from 2025 revenue of about $2.78 billion, growing about 5x over ten years requires roughly a 17.5% revenue CAGR. Because the base will keep getting larger, this means the first few years need to stay around 30%, while the back half still cannot fall below double digits. Under the report's framing, Axon already delivered a four-year CAGR of about 33.9% from 2021-2025, the company raised 2026 guidance to 30%-32%, and future contracted bookings of about $14.3 billion and RPO of about $9.7 billion provide a thick runway. So growing 5x is realistic. It is the most credible of the three conditions.

  2. Profit and cash conversion must improve substantially and persistently. This is the key constraint. 2025 GAAP net margin was only 4.5%, and free cash flow was only about $155 million. To support a fivefold stock outcome, revenue rising 5x is not enough. The company must materially reduce the share of about $634 million of stock-based compensation, ease working-capital consumption, and lift adjusted EBITDA margin from 25.5% further upward, turning attractive gross margin into true owner cash. The company's 2026 FCF target of about $450 million and promise to bring SBC dilution below 2.5% in 2028 are the tests here. This is realistic but tight, and it must be proven by execution.

  3. The valuation multiple cannot collapse materially, which is the most fragile condition. This is the decisive variable. The trailing P/E today is about 185x. If fundamentals grow 5x over ten years but the market cuts the multiple from about 185x to 35-45x, a mature high-quality software range, meaning the multiple shrinks by about 4x, then performance x5 and multiple /4 leaves only about 1.25x. The fivefold return disappears. In other words, to rise fivefold in ten years, Axon either needs results far above 5x, perhaps 7 or 8x, to offset multiple contraction, or the market must still be willing to assign it a far higher multiple than peers ten years from now. From a Baillie perspective, this condition is not under the company's control; it is set by market sentiment, making it the least reliable.

  What today's share price around $450 implies:

  At a lower price of about $400.9 and market cap of about $32.86 billion, the report already calculated that the then-current price broadly required Axon to compound owner earnings at close to more than 20% for the next decade and still command a high quality premium in the mid-2030s to be called reasonable. Now that the share price has risen to about $450 and the market cap to about $37 billion, embedded expectations are higher, not lower. A few quantitative anchors:

  • Trailing P/E is about 185x (stockanalysis, further amplified because 2025 net income was compressed to about $124.7 million);
  • Even using the company's 2026 FCF target of about $450 million, the shareholder free cash flow yield on a roughly $37 billion market cap is only about 1.2%;
  • In the report's three-scenario DCF, the most optimistic case, with owner earnings starting at $450 million, growing 20% annually, discounted at 9%, and a 3.5% terminal growth rate, produces about $373 per share. That is already quite aggressive, yet still below today's roughly $450 price.

  In other words, today's stock price is already above the report's own optimistic scenario. Market pricing is not merely reasonably expensive; it has prepaid almost all the good news of the next decade. Under the report's framing, the current price was already about 74% above its median reasonable intrinsic value of about $230 and above the upper end of the optimistic range at $380. At the higher current price, the premium has expanded further.

  Are these conditions realistic? An honest directional view:

  Condition 1, growing 5x, is realistic. Condition 2, large improvement in profit/cash, is realistic but requires execution and is tight. Condition 3, no multiple collapse, is the least realistic. Starting from about 185x, any mean reversion toward mature multiples would swallow most of the gain. So a fivefold return in ten years is not impossible for Axon, but it requires all three things to hit at the same time and in the favorable direction, especially a market still willing to grant it a far higher valuation than peers ten years from now. That is the fundamental reason the report keeps the rating at Watch and lists excessive valuation as today's most realistic and most easily overlooked risk.

  Baillie-style summary: Axon fully has the business quality of a fivefold-in-ten-years candidate, with a long slope, wide moat, and strong upsell. But the arithmetic of a fivefold return requires business performance, earnings quality, and valuation to all cooperate. At today's roughly $450 price and about 185x trailing P/E, the stock has already borrowed the optimistic case for the first two and treated the third, perpetual high multiples, as a given. The result is that buyers are no longer earning the growth dividend; they are betting that growth is realized perfectly and the market never re-rates the stock. That is an asymmetric and price-unfriendly wager with almost no margin of safety.

  Jun 10, 2026
• QWhy has the market not realized all this yet? Is it because the market does not understand, looks down on it, or cannot look far enough? What will become the narrative inflection point?2/10

  A

  Conclusion: the market has already understood and respected Axon. It is not an ignored dusty stock; it is a fully, even over-priced, star stock, with a trailing P/E of about 185x and a 52-week high that once touched $885. The real disagreement is not whether the market realizes how good it is, but how much the market is willing to pay for that quality and how long it can tolerate imperfection. The narrative inflection point will not come from discovering that Axon is a good company; it will come from events that knock down the premium, such as growth deceleration, internal-control/dilution shocks, or the valuation framework reverting from high growth to high-quality industrial software.

  The standard template for this Baillie question is whether the market does not understand, looks down on it, or cannot look far enough. With Axon, that template needs to be honestly inverted, because this is exactly the kind of company the market understands too well and values too highly. Forcing a hidden-gem narrative onto it would distort the case.

  Does the market not understand it? Basically no. Axon's story has been thoroughly explained by sell-side analysts and growth funds: public safety operating system, AI report writing, 911, drones, 125% net revenue retention, and $14.3 billion of future contracted bookings. These are open cards studied repeatedly and written into every report. The report itself says the strongest bear argument is not that Axon is not a good company, but that Axon is very likely an excellent company whose current buyers have already paid in advance for almost all the good news of the next ten years. When bulls and bears both agree this is a good company, lack of understanding is no longer the main issue.

  Does the market look down on it? The opposite: it assigns an extremely high premium. The current trailing P/E is about 185x, and market cap is about $37 billion. Under the report's framing, the current price is about 74% above its median reasonable intrinsic value of about $230 and above its own optimistic DCF of about $373 per share. Over the past year, the stock's 52-week range of about $339-$885 was violently volatile, which itself shows the market does not ignore Axon; it swings emotionally over how high the valuation should be. This is over-respect, not neglect.

  So where is the real disagreement, or perception gap? It lies in three more specific areas. These are the things the market may not have fully priced in:

  1. The market may under-discount financial statement quality and owner cash. Most momentum buyers focus on revenue growth and ARR, but can underweight that 2025 GAAP net margin was only 4.5%, free cash flow was only about $155 million, stock-based compensation was as high as about $634 million, and the material weakness in revenue-recognition internal controls still has not been fully remediated. A 185x multiple to some extent uses the high-growth narrative to cover the fact that truly distributable cash is far below headline numbers. The market has not failed to see the quality; it may have failed to discount the accounting messiness enough.

  2. The market may overestimate the durability of high multiples. Today's price implies that the market will still be willing to grant Axon a valuation far above peers ten years from now. Compare that with the reality of Motorola Solutions at about $6.7 billion in revenue and much more moderate valuation multiples. Once growth moves from 30%+ back to the mid-teens, market willingness to pay a growth premium may contract quickly.

  3. It is the opposite of not looking far enough; the market may be looking too far: it has discounted future greatness into today's price. The report's core judgment is exactly that Axon has prepaid future greatness through an extremely high valuation.

  What will become the narrative inflection point? For Axon, the inflection point is almost certain to be an event that removes the high premium, not one that discovers value. The report has effectively listed the signals that would overturn the bullish case, and they map to narrative inflections:

  • Growth deceleration breaks the story: ARR growth clearly falling below 20% and NRR persistently falling below 115% (current NRR is still 125%) would be the most direct valuation killer, because a 185x multiple rests entirely on perpetual high growth.
  • Cash conversion remains below guidance: if the 2026 FCF target of about $450 million is not delivered, the narrative of a good business that does not generate cash becomes confirmed.
  • Internal-control/dilution shocks: if the revenue-recognition material weakness remains unresolved or SBC dilution rises instead of falling, the market will re-discount the high-quality premium.
  • Competition and acquisition blowback: large customers shifting in an organized way to Motorola or open architectures, or acquisitions producing goodwill impairments/integration failures.
  • Valuation-regime shift: changes in macro rates or risk appetite cause the market to re-rate Axon from platform high-growth to high-quality industrial/software hybrid. Even if the business remains unhurt, multiple contraction alone could halve the stock.

  Baillie-style summary: Axon does not fit the classic dusty-gem narrative in which the market has not realized how good it is. The market has realized it, and has bought that quality up to about 185x trailing earnings. What the market may truly underprice is the discount factor of messy accounting, weak cash conversion, and the difficulty of sustaining high multiples forever. The narrative inflection point will not be that everyone finally discovers gold; it will be any of growth deceleration, cash shortfall, internal-control shock, or valuation-regime normalization forcing out today's prepaid optimism in one move. For a Baillie-style long-term growth investor, this means the answer to whether one wants to own the business is yes, but buying it at this price means betting on the fragile premise that the market never re-rates it. That is exactly why the report lands at Watch.

  Jun 10, 2026